Volume

Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma

Research advances and new challenges in overcoming triple-negative breast cancer

Emerging RAS-directed therapies for cancer

The implication of liquid biopsies to predict chemoresistance in pancreatic cancer

Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer

Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (<i>EGFR</i>)-mutations in first-line for advanced non-small cell lung cancer

Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy

Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells <i>in vitro</i>

Favorable clinical outcomes of checkpoint inhibitor-based combinations after progression with immunotherapy in advanced non-small cell lung cancer

Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment

ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an <i>in vivo </i>model

Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment

Drug resistance in targeted cancer therapies with RAF inhibitors

Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/